BridgeBio Pharma (BBIO) PT Raised to $106 at Mizuho
Tweet Send to a Friend
Mizuho analyst Salim Syed raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $106.00 (from $91.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
